chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body aches; Chills; headache; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2020, the patient received the 2nd dose of Shingrix. In May 2020, immediately after receiving Shingrix, the patient experienced general body pain, chills and headache. On an unknown date, the outcome of the general body pain, chills and headache were not recovered/not resolved.   It was unknown if the reporter considered the general body pain, chills and headache to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The age group was not reported but it was selected as adult as per the vaccine indication. The patient just received the shingrix vaccine and had body aches, chills and headache. The reporter asked how long the symptoms last.
Screw this vaccine. A relative has become magnetic at the site; Initial information received 10-May-2022 regarding an unsolicited valid Social Media non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient who experienced screw this vaccine. a relative has become magnetic at the site while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number expiry date was unknown)  via unknown route in unknown administration site for Prophylactic vaccination.  On an unknown date the patient developed a non-serious screw this vaccine. a relative has become magnetic at the site (vaccination site reaction) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (Screw this vaccine. A relative has become magnetic at the site).  At time of reporting, the outcome was Unknown for the event screw this vaccine. a relative has become magnetic at the site.
Breastfeeding; A spontaneous report was received from a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and is breastfeeding.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Lot: unknown) intramuscularly for prophylaxis of COVID-19.  On an unknown date, the patient stated that she is breastfeeding and inquired about study enrollment. No treatment information provided.   Treatment was not provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome for the event, breastfeeding, was unknown.; Reporter's Comments: This is a case of product exposure during breastfeeding with no associated AEs. Patient will continue to be contacted for further monitoring of AEs.
pt recv vax 20OCT98 & devel an inj site rxn characterized by pain, redness, itching & warmth;also felt like was coming down w/something;
Anaphylaxis. About 30 minutes after receiving the first dose of the Pfizer Covid vaccine, patient developed shortness of breath associated with hives throughout the entire body. Patient's tongue, face and throat started to swell. EMS gave 0.3 mg IM epinephrine and 50 mg  Benadryl after which patient reported improvement of swelling in his throat and face. Upon arrival to ED, Pepcid and Solumedrol were administered and began LR IV fluid. Patient remained stable and felt much improved. ED provider discussed and counseled patient on condition. Prescriptions provided including Epi pen, and warned about possible delayed reaction.
I took 3 ibuprofen (200 mg each), before going to bed at 9:30pm just in case I did get some aches or pains from the shot. I woke up at 1:30am freezing cold and hurt so bad I couldn't get out of bed. 45 minutes later I managed to get to the bathroom and took my temp which was 103.2. I took more ibuprofen, the fever subsided to 101. I continued having a fever for 2 days along with body aches and feeling very tired. Felt fully recovered after 4 days.
On 3/31, I started itching on my right arm, and when I rolled up my sleeve, I had 3-4 areas of rash, not sure where it came from, but wanted to report that I did take the shot.
Lump on left arm since 5-13-18 PM pain to brush against, no discharge, no other lumps, no fevers. Exam findings - tender palpable lump deep in deltoid. Borders palpable, feels soft, deltoid muscle abscess, cutaneous absess, fatigue. Ordered CBC, ultrasound conclusive for abscess. Prescribed KEFLEX. If WBC is elevated will need surgical evaluation.
I got tinnitus a month after the vaccine. I was not able to sleep for two weeks and a half, and I had to ask my employer for a semester medical leave because I was going mad, with crisis of anxiety and insomnia, I saw 2 audiologists  and they said the my ear was ok. I saw to ear and nose doctors , and they confirm I have tinnitus. They told me there is not cure for that, and that I should learn to live with it. I am now working with doctors here. The tinnitus is permanent. The first week, a doctor prescribe my medication for anxiety and insomnia, clonazepan and quetiapine, and was able to sleep. I am taking Quetiapine now and taking classes to control my mind.
numbness; The Initial case was missing the following minimum criteria: ICH-unspecified AE. Upon receipt of follow-up information on 18Jan2022, this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (002191; 005570; 159558). The reporter is the patient.  A 41 year-old female patient received bnt162b2 (BNT162B2), administration date Apr2021 (Batch/Lot number: unknown) at the age of 41 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPOAESTHESIA (hospitalization) with onset 2021, outcome "unknown", described as "numbness". The event "numbness" was evaluated at the emergency room visit. Clinical course: The patient recently had the Pfizer COVID injection vaccine in Apr2021 and had a serious reaction to it where she went to hospital where they did all kinds of tests. The patient had complications with the shot and had to go to the emergency room and as a result she had additional medical bills that she wasn't anticipating. The patient added that the numbness and everything that she experienced after her first dose had come back. All the medical personnel have advised the caller that it is a good thing she didn't have a second dose.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Swollen arm around injection site about 6? red knob throbbing and sore Headache tired 99.2 fever
17-year-old patient received Moderna 1st dose on 3/30/21 without adverse reaction.
Exhaustion, headache, fever, chills, nausea, weakness, pain in injection site, pain in joints/muscles (neck and back)
On day 7 I woke up with a firm itchy lump  at the injection site. No symptoms prior to today other than soreness at the site.
The pt experienced a pruritic macular erythematous rash. Onset was 8-10 hours post vax. 1 day post vax, the pt experienced a sore throat, 2 days post vax the pt developed myalgias and fever.
"39 y/o female with a 3 day history of rash within 12 hours after 2nd COVID shot. In the left deltoid. Had same after first. Wax and wane for 3 weeks. Arm was sore for first 2 days, better now. This one is larger, more itchy. Otherwise feels fine. Has reported to CDC."
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.  On 28-Feb-2021 at 9:14 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Feb-2021 at 9:14 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 31.44 for dose administered on 28-Feb-2021 .  Concomitant product use was not provided by the reporter.  Batch number 014M20A underwent temperature excursion on 28-Feb-2021 with temperature 26 and 27 degrees Fahrenheit from 09:00 AM to 01:00 PM. This vial was moved to fridge on 24-Feb-2021 and beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 27-Feb-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  Treatment information was not provided.   This case was linked to MOD-2022-566976 (Patient Link).
Feeling of skin burning on neck, back, chest and arms. No rash or marks. Skin hypersensitivity feeling similar to sunburn. Onset 6-7 days after injection. Sensation still ongoing after 2-3 days.
8hrs post vax pt developed fever, insomnia, reduced concentration, dec appetite; resolved partially by 6MAY91 w/only residual fatigue;
within a couple of hours of getting my first dose, I could feel the congestion breaking up and my sinus passages clearing; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (within a couple of hours of getting my first dose, I could feel the congestion breaking up and my sinus passages clearing) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic sinusitis (decades long), Drug allergy (Atropine) and Congestion nasal (Nasal congestion). Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA), METFORMIN from 03-Feb-2017 to an unknown date and ATORVASTATIN for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (within a couple of hours of getting my first dose, I could feel the congestion breaking up and my sinus passages clearing). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (within a couple of hours of getting my first dose, I could feel the congestion breaking up and my sinus passages clearing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.  Patient had chronic sinus issues for years/decades long and within a couple of hours of getting his first dose, he could feel the congestion breaking up and his sinus passages clearing.  It was not 100% better, but noticably improved.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Concomitant medication added, event outcome change unknown to not recovered, event added, and narrative updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pediarix given 5/10/05. 6/20/05 seen complaining of cough for 3 weeks. Albuterol syrup given and follow up in 7-10 days. 6/27/05 Follow up S/P ER visit for 24 hours observation on 6/25/05. Continue E-mycin and Zantac. Follow up in 10 days. 7/11/05 Continue course E-mycin. Follow up when complete.
I gave the 5-12yr old dose of covid vaccine to my 15 year old patient at 3:07pm on 6/27/2022. The patient remained stable with no adverse reactions noted. The patient was kept in the clinic for monitoring and the PCP was notified and spoke with the parent.
Her allergies include a delayed reaction to the Pneumovax 23 vaccine that made her entire arm swell to her wrist; This spontaneous report was received from a female consumer of unknown age referring to herself. The patient's pertinent concurrent conditions included sjogren's syndrome. The patient medical history and concomitant medications were not provided.      On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) as prophylaxis (concentration, vaccination scheme frequency, dosage, route of administration and anatomical location, lot number and expiration date were not reported).   On an unknown date, the patient stated that ,she had a delayed reaction to pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), that made her entire arm swell to her wrist (peripheral swelling). At the time of this report, the outcome of peripheral swelling was not reported.     As the patient reported having an adverse reaction to pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), , therefore the causality is being considered as related.
Administered 1st dose on the Tricep Area; Experienced soreness in the tricep area; This is a spontaneous report from a contactable consumer, reporting for the spouse, from a Pfizer-sponsored program.  A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the triceps area on an unknown date as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  On an unknown date, the patient received the vaccine in the triceps area instead of the deltoid. The patient experienced soreness in the triceps area. The clinical outcome of soreness in the triceps area was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Flushing, tachycardia, and hypertension.  Required Benadryl 37.5 mg oral and IM Solumedrol 40 mg. which resolved tachycardia and hypertension
No adverse event; HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL); This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL)) and NO ADVERSE EVENT (No adverse event) in a 2-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Relevant medical history or conditions, allergy, concomitant diseases, and risk factor were unknown.     On 27-Jul-2023, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Jul-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL)).    Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter. This case contains information about 7th patient out of 12.
Rash started on 1/16/07 on face and around ears. Spreading all over body, palms and sole, itchy. No fever. Rash erythematous hives, of varying size 3-4 inch to small macula, blanching, few have central cleaning, measle like rash. Medicated with Benadryl.
Redness and swelling in upper right arm; pain and burning sensation in upper right arm; pt unable to sleep for 2 days because of pain.  Pt took Excedrin and aspirin, but had no relief; also applied Tiger Balm patches.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22May2022 as dose 4 (booster), single (Lot number: FM0173) at the age of 64 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Sulfa" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Tetracycline, reaction(s): "Known allergies: Tetracycline". The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) Negative; (18Jul2022) Positive. Therapeutic measures were taken as a result of covid-19.  Clinical course: Horrid taste while taking Paxlovid,went away when course was done. Covid recurrence (positive test) 7 days after previously negative test on last day of course. Still positive at present.
firmness at injection site; itching at injection site; red at injection site, pink at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (firmness at injection site), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE ERYTHEMA (red at injection site, pink at injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031420A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included METFORMIN, GLIPIZIDE, METOPROLOL, LISINOPRIL and WARFARIN for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INJECTION SITE REACTION (firmness at injection site), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE ERYTHEMA (red at injection site, pink at injection site). At the time of the report, INJECTION SITE REACTION (firmness at injection site), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE ERYTHEMA (red at injection site, pink at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
On 8/21/01, client came to clinic for TB test reading. She stated that MMR site had began to redden and swell within a day, post vax. The area of right arm was examined and was warm to the touch. There was a 1 1/2" X 2" area that was pink per caller, noted below injection site. Pt was advised to seek medical care. On 8/27/01, received telephone call from pt stating the she was unable to see physician (clinic closed) but the area was less warm and smaller in size.
Information has been received from a consumer concerning an approximately 5 - 12 year old child who in approximately 1996 - 2003 was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient experienced a mild case of chickenpox. Unspecified medical attention was sought. The patient subsequently recovered. There was no product quality complaint involved. Additional information has been requested.
Pt recv vax and exp swollen arm.  Pt dx cellulitis by her physician. Pt tx=aspirin and compresses.  Pt recovered after a few days.
LEFT SHOULDER WAS SO STIFF AND PAINFUL THAT I COULDN'T USE MY ARM AT ALL.  STIFFNESS AND PAIN INCREASED WITH EACH DAY NOT HAVING ANY MOTION IN THAT ARM AT ALL.  AFTER 4 OR 5 DAYS I ALSO HAD PAIN IN MY RIGHT SHOULDER AND JOINTS.  I WAS ALSO VERY NAUSEOUS AND ON APRIL 6TH AND 7TH I EXPERIENCED DEEP SWEATS DURING THE NIGHT.  AT THAT POINT THE PAIN STARTED TO DECREASE AND I STARTED TO SLOWLY GET MOTION BACK IN MY ARM.  I WENT TO AN ORTHOPAEDIC DOCTOR WHO ASSURED ME THAT THIS WAS A REACTION TO THE SHOT.